Description
AMPYRA DALFAMPRIDINE 10MG, TABS
First action · last action
2011-10-01 · 2011-10-01
Transactions
1
First transaction's obligation
$96,000
Base + all options value (sum of deltas)
$96,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0459
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-10-01+$96,000= $96,000
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-10-01 | +$96,000 | $96,000 | AMPYRA DALFAMPRIDINE 10MG, TABS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI R5D3FUPFFPK4)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77024N0067 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $493,607 | FY2024 |
| 36E79724A0005 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2024 |
| 36C77024N0027 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $444,505 | FY2024 |
| 36F79723D0194 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36E79723A0011 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C77023N0057 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $529,877 | FY2023 |
Other recipients under 6505 from 262-NETWORK CONTRACT OFFICE 22 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26216J3405 | SANOFI VACCINES US INC. | 262-NETWORK CONTRACT OFFICE 22 | $209,679 | FY2016 |
| VA26216P3483 | JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC. | 262-NETWORK CONTRACT OFFICE 22 | $14,960 | FY2016 |
| VA26216E3967 | MCKESSON CORPORATION | 262-NETWORK CONTRACT OFFICE 22 | $20,913,958 | FY2016 |
| VA26216P2987 | PETNET SOLUTIONS, INC. | 262-NETWORK CONTRACT OFFICE 22 | $58,136 | FY2016 |
| VA26216E3446 | MCKESSON CORPORATION | 262-NETWORK CONTRACT OFFICE 22 | $11,612,703 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26212F0582_3600_VA797BP0459_3600 · retrieved 2026-09-26.